查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598508

经皮电神经刺激市场：按手术技术、产品和最终用户划分 - 全球预测 2025-2030

Transcutaneous Electrical Nerve Stimulation Market by Surgery Procedures (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), Product (Desktop, Portable), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年经皮皮电神经刺激市值为3.3669亿美元，预计2024年将达到3.4882亿美元，复合年增长率为3.69%，2030年将达到4.3408亿美元，预计将达到1000万美元。

经皮神经电刺激 (TENS) 是治疗方法。 TENS 的应用范围包括各种疼痛管理应用，例如慢性下背痛、关节炎和纤维肌痛，最终用途包括医疗机构、诊所和家庭护理机构。由于人们对鸦片类药物危机的认识不断提高以及对替代疗法的需求增加，人们对非侵入性、无药物的止痛解决方案的日益偏好也支持了对 TENS 的需求。影响 TENS 市场成长的关键因素包括技术进步，例如提高移动性和便利性的无线 TENS 设备、更容易患疼痛相关疾病的全球人口老龄化以及慢性疼痛患者数量的增加。最近的技术创新，例如与行动应用程式整合的可穿戴 TENS 设备，用于个人化治疗，带来了巨大的成长机会。此外，扩大监管核准和增加研发投资以提高疗效和病患治疗效果也凸显了市场参与者的有利领域。

主要市场统计
基准年[2023] 33669万美元
预测年份 [2024] 34882万美元
预测年份 [2030] 43408万美元
复合年增长率（%） 3.69%

儘管如此，市场面临可能阻碍成长的挑战，包括严格的监管障碍和报销问题。对 TENS 在严重疼痛管理方面的有效性的怀疑以及来自药物和其他电疗设备等替代疗法的竞争也构成了障碍。为了利用市场机会，公司应该投资穿戴式装置的开发和人工智慧主导的分析，以实现更个人化的疼痛管理。将 TENS 与其他治疗方法结合以改善疼痛缓解效果的研究可以提供竞争优势。此外，旨在解决对临床效率的怀疑的教育宣传活动和游说有利的报销政策可能会增加市场采用率。总体而言，只要透过策略倡议和技术进步克服现有挑战，TENS 市场仍然充满活力，并且具有巨大的创新潜力。

市场动态：快速发展的经皮电神经刺激市场的关键市场洞察

供需的动态交互作用正在改变经经皮神经电刺激市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 物理治疗师越来越青睐肌肉刺激器
    • 运动医学中越来越重视疼痛管理治疗
    • 人群中肌肉骨骼疾病的盛行率上升
  • 市场限制因素
    • 神经刺激治疗的成本增加
  • 市场机会
    • 医疗保健领域使用的机器不断进步和现代化
    • 活性化医疗保健领域的研发活动
  • 市场挑战
    • 缺乏熟练且训练有素的医生

波特五力：驾驭经皮电神经刺激市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对经皮电神经刺激市场的外在影响

外部宏观环境因素在塑造经皮电神经刺激市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解经皮神经电刺激市场的竞争格局

经皮电神经刺激市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵经皮电神经刺激市场供应商的绩效评估

FPNV 定位矩阵是评估经皮电神经刺激市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了经皮电神经刺激市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对经皮电神经刺激市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肌肉刺激器在物理治疗师中越来越受欢迎
      • 疼痛管理治疗在运动医学的重要性日益增加
      • 该国肌肉骨骼疾病的盛行率正在增加。
    • 抑制因素
      • 神经刺激治疗的成本增加
    • 机会
      • 医疗保健领域所用机器的技术进步与现代化进步
      • 医疗保健领域的研发活动增加
    • 任务
      • 缺乏熟练且训练有素的医生
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

经皮外科手术经皮电神经刺激市场

  • 直接神经修復
  • 神经移植
  • 干细胞疗法

第七章经皮电神经刺激市场：副产品

  • 桌面
  • 可携式的

第八章经皮电神经刺激市场：依最终用户分类

  • 诊所
  • 医院

第九章美洲经皮电神经刺激市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太经经皮电神经刺激市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲经皮神经电刺激市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • BioMedical Life Systems
  • Bioness, Inc.
  • Boston Scientific Corporation
  • Chirag Electronics Private Limited, Smra
  • Cochlear Ltd
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO LLC.
  • ElectroCore, Inc.
  • EMS Physio Ltd
  • Medtronic plc
  • NeuroMetrix, Inc.
  • NeuroPace Inc
  • Nevro Corp
  • OMRON Corporation
  • R-slimming Medical Systems
  • Uroplasty, Inc.
  • Zynex Medical
Product Code: MRR-0355054AC4CA

The Transcutaneous Electrical Nerve Stimulation Market was valued at USD 336.69 million in 2023, expected to reach USD 348.82 million in 2024, and is projected to grow at a CAGR of 3.69%, to USD 434.08 million by 2030.

Transcutaneous Electrical Nerve Stimulation (TENS) is a therapeutic modality that utilizes low-voltage electrical current to relieve pain. The scope of TENS includes its application in various pain management contexts such as chronic back pain, arthritis, and fibromyalgia, and its end-use spans across healthcare facilities, clinics, and homecare settings. The necessity of TENS is underscored by the growing preference for non-invasive and drug-free pain relief solutions, driven by increasing awareness of the opioid crisis and the demand for alternative therapies. Key factors influencing the growth of the TENS market include advancements in technology, such as wireless TENS units, which offer enhanced mobility and convenience; an aging global population predisposed to pain-related ailments; and an expanding base of chronic pain sufferers. Recent innovations, such as wearable TENS devices integrated with mobile apps for personalized treatment, present significant growth opportunities. Moreover, expanding regulatory approvals and increased investment in R&D to enhance efficacy and patient outcomes highlight lucrative areas for market players.

KEY MARKET STATISTICS
Base Year [2023] USD 336.69 million
Estimated Year [2024] USD 348.82 million
Forecast Year [2030] USD 434.08 million
CAGR (%) 3.69%

Nevertheless, the market faces challenges such as stringent regulatory hurdles and reimbursement issues that may hinder growth. Skepticism regarding the efficacy of TENS in managing severe pain and competition from alternative treatments like pharmaceuticals and other electrotherapy devices also pose hurdles. To capitalize on market opportunities, businesses should invest in developing wearable devices and AI-driven analytics for more personalized pain management. Research into combining TENS with other therapies to enhance pain relief outcomes could present competitive advantages. Moreover, educational campaigns to address clinical efficiency skepticism and lobbying for favorable reimbursement policies can expand market adoption. Overall, the TENS market remains dynamic with significant potential for innovation, contingent on overcoming existing challenges through strategic initiatives and technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transcutaneous Electrical Nerve Stimulation Market

The Transcutaneous Electrical Nerve Stimulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising popularity of muscle stimulators among physiotherapists
    • Increasing emphasis on pain management therapies in sports medicine
    • Rising prevalence of musculoskeletal disorders among citizens
  • Market Restraints
    • Increased cost of nerve stimulation therapy
  • Market Opportunities
    • Rising technological advancements and modernization in the machinery used in healthcare sector
    • Rising research and development activities in the healthcare sector
  • Market Challenges
    • Lack of skilled or trained physicians

Porter's Five Forces: A Strategic Tool for Navigating the Transcutaneous Electrical Nerve Stimulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transcutaneous Electrical Nerve Stimulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transcutaneous Electrical Nerve Stimulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transcutaneous Electrical Nerve Stimulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transcutaneous Electrical Nerve Stimulation Market

A detailed market share analysis in the Transcutaneous Electrical Nerve Stimulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transcutaneous Electrical Nerve Stimulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transcutaneous Electrical Nerve Stimulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transcutaneous Electrical Nerve Stimulation Market

A strategic analysis of the Transcutaneous Electrical Nerve Stimulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transcutaneous Electrical Nerve Stimulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, BioMedical Life Systems, Bioness, Inc., Boston Scientific Corporation, Chirag Electronics Private Limited, S.m.r.a, Cochlear Ltd, Cogentix Medical, Inc., Cyberonics, Inc., DJO LLC., ElectroCore, Inc., EMS Physio Ltd, Medtronic plc, NeuroMetrix, Inc., NeuroPace Inc, Nevro Corp, OMRON Corporation, R-slimming Medical Systems, Uroplasty, Inc., and Zynex Medical.

Market Segmentation & Coverage

This research report categorizes the Transcutaneous Electrical Nerve Stimulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgery Procedures, market is studied across Direct Nerve Repair, Nerve Grafting, and Stem Cell Therapy.
  • Based on Product, market is studied across Desktop and Portable.
  • Based on End User, market is studied across Clinics and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising popularity of muscle stimulators among physiotherapists
      • 5.1.1.2. Increasing emphasis on pain management therapies in sports medicine
      • 5.1.1.3. Rising prevalence of musculoskeletal disorders among citizens
    • 5.1.2. Restraints
      • 5.1.2.1. Increased cost of nerve stimulation therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancements and modernization in the machinery used in healthcare sector
      • 5.1.3.2. Rising research and development activities in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled or trained physicians
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transcutaneous Electrical Nerve Stimulation Market, by Surgery Procedures

  • 6.1. Introduction
  • 6.2. Direct Nerve Repair
  • 6.3. Nerve Grafting
  • 6.4. Stem Cell Therapy

7. Transcutaneous Electrical Nerve Stimulation Market, by Product

  • 7.1. Introduction
  • 7.2. Desktop
  • 7.3. Portable

8. Transcutaneous Electrical Nerve Stimulation Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospital

9. Americas Transcutaneous Electrical Nerve Stimulation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aleva Neurotherapeutics SA
  • 3. BioMedical Life Systems
  • 4. Bioness, Inc.
  • 5. Boston Scientific Corporation
  • 6. Chirag Electronics Private Limited, S.m.r.a
  • 7. Cochlear Ltd
  • 8. Cogentix Medical, Inc.
  • 9. Cyberonics, Inc.
  • 10. DJO LLC.
  • 11. ElectroCore, Inc.
  • 12. EMS Physio Ltd
  • 13. Medtronic plc
  • 14. NeuroMetrix, Inc.
  • 15. NeuroPace Inc
  • 16. Nevro Corp
  • 17. OMRON Corporation
  • 18. R-slimming Medical Systems
  • 19. Uroplasty, Inc.
  • 20. Zynex Medical

LIST OF FIGURES

  • FIGURE 1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023